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Introduction
Several traditional risk factors [1] [2] [3] have been identified as risk factors for the increased mortality of endstage renal disease (ESRD) patients [4] . In particular, ESRD patients are characterized by accelerated arteriosclerosis, diseases associated with vascular calcification of intima and media and arterial stiffening [5, 6] . Therefore, ESRD patients could serve as an in vivo model for calcification. Recent studies demonstrate an augmented intima media thickness (IMT) and an increased pulse wave velocity (PWV) in ESRD patients. Since IMT and PWV are proportional to calcification [7] , these parameters are capable surrogate markers for vascular calcification.
Several inhibitors of calcification processes are already known, e.g. osteoprotegerin [8] and pyrophosphate [ e.g. 8] . While bone turnover is controlled by the receptor activator of nuclear factor-B ligand osteoprotegerin [9] , the RANKL/OPG axis plays an important role in balancing bone calcification [10] . Accordingly, as vascular calcification is claimed to be similar to bone calcification, RANKL/OPG is also involved in vascular calcification [11] . Recent studies demonstrated an increased vascular calcification in vascular smooth muscle cells (VSMC) incubated with RANKL and no vascular calcification after adding osteoprotegerin [9] .
However, recent studies also demonstrate that additional inhibitors are involved in the regulation of calcification processes. In vitro studies suggested Mg 2+ to be a potent inhibitor of the vascular calcification process, which implies to consider Mg 2+ as a potential candidate for the prevention and/or therapy of vascular calcification [10] . Vascular cells have been thought to play a passive role in vascular calcification. In contrast to this paradigm, recent studies have demonstrated that vessel wall cells actively contribute to calcification process by transdifferentiating into osteoblast-like cells [12, 13] .
The majority of in vitro studies on the mechanism of calcification were based on isolated cells like VSMC. The lack of vessel matrix and natural architecture of vessels are strong limiting factors in these models. Therefore, in the present study, an ex vitro/in vivo model of isolated aortic ring with a long-term culture was used [14] to investigate the effect of Mg 2+ on vascular calcification within the natural architecture of the vessels. To investigate the clinical impact of the in vitro findings, we additionally studied the association of Mg 2+ serum concentration on surrogate parameters for arteriosclerosis in vivo in patients with and without chronic kidney disease (CKD).
Methods

Effect of Mg 2+ on Aortic Vascular Calcification ex vivo/in vitro
Aortas from male Wistar-Kyoto rats were gently dissected, the adventitia was manually removed without injuring the vessels, cut and divided into segments (3-4 mm) and transferred into Dulbecco's Modified Eagle's Medium (DMEM) in the presence of 5 vol% CO 2 at 37 ° C. Since serum is causing outgrowth and proliferation of VSMC [14] and other side effects on VSMC [15] , serum was not added to the culture medium.
Aortic segments placed into DMEM were incubated in the presence of penicillin and streptomycin (1%) and 5 vol% CO 2 at 37 ° C for a maximum of 7 days. The medial calcification is thought to be caused amongst others through evaluated Ca 2+ and PO 4 3 + plasma concentrations which excess the solubility limit of calcium phosphate in the form of hydroxyapatite crystallization [14] . Therefore, the phosphate level was elevated from 0.9 to 3.8 mmol/l by either the addition of 100 mmol/l NaH 2 PO 4 to the incubation media, after equilibrating the medium at 5% CO 2 to prevent alkalization and precipitation of calcium phosphate, or by adding ␤ -glycerophosphate (BGP; 10 mmol/l) to media and ascorbic acid (0.1%) as a cofactor for alkaline phosphatase. The aortic segments were incubated in the absence and presence of 3 mmol/l MgCl 2 .
The dried aortic rings were dissolved in 0.6 mol/l HCl. The calcium content was quantified by using the QuantiChrom TM Ca 2+ assay kit (DICA-500) according to the manufacturer's protocol. Briefly, equal amounts of reagent A ( o -phthalic acid, polyvinylpyrrolidone, methylthymol blue, hydroxyquinoline) and reagent B (sodium sulfite, monoethanolamine) were placed in a 96-well plate and 5 l of the sample was added. The UV absorption at 612 nm was measured ( fig. 1 a) .
The Mg 2+ content was quantified by using the QuantiChrom TM Mg 2+ assay kit (DICA-500) according to the manufacturer's protocol. 200 l in equal amounts of reagent A (2-amino-2-methyl-1-propanol, caffeine, thiourea, potassium chloride) and reagent B (calmagite, EGTA, dimethylsulfoxide) were placed in a 96-well plate and 5 l of the sample was added. The UV absorption at 500 nm was measured.
For histochemical analyses the segments were placed in 1 ml formaldehyde 4%. The tissues were stained for hematoxylin and eosin after sectioning and von Kossa staining was performed. The specimens were incubated for 90 min in 5% (w/v) AgNO 3 , rinsed with water and incubated in 2.5% (w/v) Na 2 S 2 O 3 . After counterstaining with nuclear fast red, the sections were dehydrated and mounted in Entelan mounting medium.
Immunohistochemical analyses on paraffin sections for polyclonal rabbit anti-rat osteocalcin (Acris Antibodies) were performed for polyclonal goat anti-rat osteopontin (Santa Cruz Biotechnology) and for polyclonal goat anti-rat FGF-23 (Santa Cruz Biotechnology). In brief, slides were pretreated with heat (96 ° C in a water bath), followed by blocking of endogenous peroxidase with 1% H 2 O 2 as well as endogenous biotin by a TNB blocking kit (Perkin-Elmer). The primary antibody was incubated overnight at 4 ° C. The samples were heated with primary antibody for 1 h at 37 ° C, followed by incubation with a biotinylated secondary goat anti-rabbit antibody/donkey anti-goat antibody (30 min, 37 ° C; Santa Cruz).
Mg
2+ Serum Concentrations and IMT and PWV in CKD Patients in vivo
97 patients were recruited from University Hospital Essen (Essen, Germany) after the local ethics committee granted project approval and after patients had given written consent. 36 patients suffered from CKD stage 5 defined as MDRD estimated glomerular filtration rate (eGFR) ! 15 ml/min/1.73 m 2 or depending on dialysis. 61 patients had no CKD (controls) defined as eGFR 1 60 ml/min/1.73 m 2 . The patients were classified into a group with normal and a group with high serum Mg 2+ level. As threshold the concentration of 0.9 mmol/l was chosen in accordance with the mean magnesium concentration in adults [16] .
For biochemical characterization, creatinine, phosphate, serum calcium, total cholesterol, hemoglobin and albumin were measured using standard autoanalyzer techniques and intact parathyroid hormone was determined by immunoassay (Roche Diagnostics, Germany). FGF-23 was quantified in lithium-heparin plasma using a FGF-23 ELISA kit (Immutopics, USA) according to the protocol provided by the manufacturer. Optical density of the samples was measured at 450 nm and the primary and secondary standard curve assays were measured at 450 and 620 nm.
IMT was measured 1 cm proximal to the bulb of the extracranial common carotid artery by sonography by a single trained physician [ for details, see 17] . Brachial blood pressure and PWV were measured by a single trained observer after a rest in the supine position at the dominant arm as described elsewhere [18, 19] .
Blood was taken before dialysis at a single time-point. Non-hemolysed, non-icteric serum samples were directly separated from the clot and kept frozen until all samples of the collective could be measured side by side within one analysis set-up. Mg 2+ concentration in serum samples was measured using xylidyl blue reaction in alkaline medium and masking of calcium ions by EGTA (ethyleneglycol-bis(2-aminoethylether)-N,N,N ,N -tetra-acetic acid). Serum samples were immediately separated from the clot and kept frozen until all samples of the collective could be measured side by side within one analysis set-up. For photometric determination at 546 nm wavelength, serum samples were diluted at final concentrations of 0.1 mmol/l xylidyl blue and 0.13 mmol/l EGTA. concentrations of medium on incorporated Ca 2+ amount in aortic segments from rats (n = 4). f Effect of increased Mg 2+ concentrations in the medium on an incorporated Mg 2+ amount in aortic segments from rats (n = 4).
Statistics
All data are reported as mean 8 SEM. Each statistical analysis was performed with the unpaired t test. Differences were defined as significant from p ^ 0.05 ( * ), as highly significant ( * * * ) from p ^ 0.001.
Results
Incubation of Aortic Rings in the Presence of High Phosphate and Calcium DMEM Medium
A positive von Kossa staining, as a marker for calcification, was observed in aortic segments incubated in the presence of NaH 2 PO 4 as well as BGP ( fig. 1 b) compared with control media ( fig. 1 c) fig. 1 e) . The calcification processes were associated with increased expression of osteopontin ( fig. 2 a) , osteocalcin ( fig. 2 b) as well as of the anticalcification protein FGF-23 ( fig. 2 c) compared to control conditions. Immunofluorescence without primary antibody did not show any non-specific staining with secondary antibody (data not shown).
Effect of Mg 2+ on the Calcification Rate of Isolated Aortic Rings
Von Kossa staining showed less phosphate-induced calcification of aortic rings incubated in the presence of Mg 2+ ( fig. 1 d) Mg2+ /mg tissue ; n = 6) ( fig. 1 f) . However, the presence of Mg 2+ during phosphate-induced calcification had a significant decreasing effect on the expression of osteopontin, osteocalcin and FGF-23, upregulated in the presence of high phosphate concentrations ( fig. 2 ac) . Again, immunofluorescence without primary antibody did not show any non-specific staining with secondary antibody (data not shown).
Serum Mg 2+ Concentrations, PWV and IMT in Patients and Controls
To evaluate the clinical relevance of the inhibitory effect of Mg 2+ on calcification processes, we quantified serum Mg 2+ concentration, PWV and IMT. Apart from FGF-23 levels which were significantly higher in CKD patients and parameters mainly influenced by renal function (Cr, P, PTH, Hb), clinical and biochemical characteristics of CKD patients and controls were not significantly different ( tables 1 , 2 ) fig. 3 a, b) ). In contrast, CKD patients with a serum Mg ( fig. 3 c) .
Discussion
Many of the factors involved in the regulation of arterial calcification processes diminish or become deregulated by ex vivo cultivation conditions of, for example, VSMC. In contrast to previous studies investigating the Mg 2+ effect on calcification processes using ex vivo VSMC, our study investigated for the first time the effect [10] . The magnesium concentration of 3 mmol/l used in our in vitro study is due to known high Mg 2+ plasma level ranges in CKD patients from 2.5 to 3 mmol/l [10] . We were able to demonstrate that increased Mg 2+ concentrations inhibit vascular calcification in aortic segments exposed to calcification medium. VSMC are the predominant cell type within the arterial wall and are known to be strongly involved in vascular calcification processes. There are studies demonstrating that VSMC are able to transform into osteochondrocyte-and osteoblast-like cells under certain conditions given by arteriosclerotic disease or arterial injury. This transdifferentiation can be induced in in vitro studies by elevated phosphate concentrations. These osteochondrocyte-and osteoblast-like cells act like osteoblasts, chondrocytes and odontoblasts causing mineralization of bone, cartilage and dentin [20] , and initiate the formation of hydroxyapatite [21] . In the current study, whole aortic segments were used as a physiologic model, since in these model endothelial cells, VSMC, pyrophosphate, and other yet unknown factors are able to interact and the overall vascular architecture is not damaged.
The impact of FGF-23 on calcification processes is controversially discussed. While FGF-23 was discussed as a secondary appearance to the mineral metabolic disorder seen in CKD patients in former studies [20] , more recent data demonstrated that it acts as a central factor in vascular calcification. FGF-23 inhibits calcitriol production and decreases intestinal phosphate absorption [22, 23] . FGF-23 is involved in physiological regulation of phosphate serum levels through induction of phosphaturia and blockade of tubular phosphate reabsorption [24] . Furthermore, FGF-23 actively suppresses secretion of PTH [25] , thus counteracting the development of secondary hyperparathyroidism in CKD patients, one of the causes of vascular calcification [25] . FGF-23 obviously compensates failing kidney function in order to keep serum phosphate levels in the normal range as long as possible, thus FGF-23 is named a 'novel phosphaturic hormone' [24] . There are several data demonstrating that the vascular calcification process is comparable to the ossification process. The main process is based on transdifferentiation of VSMC into osteoblast-like cells [26] and the subsequent ossification of vessels in the form of calcification. Therefore, FGF-23 is also detectable in calcified cultured vessels. In addition, the detection of FGF-23 in calcified vessel cells supports the hypothesis that calcification processes of vessels are comparable to the ossification process in bone.
Accordingly, in the present study the amount of FGF-23 in aortic segments incubated in the presence of Mg 2+ was significantly lower than in the absence of Mg
2+
. Since FGF-23 expression is discussed as regulated by mineral metabolism and as a compensating mechanism of vascular calcification, the decreased expression of FGF-23 may be a consequence of a diminished calcification process in the present study.
Osteopontin and osteocalcin are expressed, while VSMC are transforming to osteochondrocyte-and osteoblast-like cells. While unphosphorylated osteopontin as in the current study has an enhancing effect on calcification processes, phosphorylated osteopontin has an inhibitory effect [27] . However, increased expression of osteopontin and osteocalcin is an indicator of transformation of VSMC to osteoblast-like cells as well as an indicator of vascular calcification [27, 28] . Since the amount of osteopontin is decreased in the presence of Mg
inhibiting the formation of hydroxyapatite crystals [29, 30] . In addition, the amount of osteocalcin in aortic segments incubated in the presence of Mg 2+ was significantly lower than in its absence. These results suggest that Mg 2+ inhibits the transformation of VSMC into osteoblast-like cells as well as hydroxyapatite crystal formation.
To evaluate these ex vivo/in vitro effects in vivo, the coherence of Mg 2+ levels and known predictive factors/ surrogate markers for vascular calcification like IMT and PWV [31] was investigated. There are studies demonstrating a strong correlation between IMT values and cardiovascular mortality in CKD patients [32, 33] . There was a significant difference between CKD patients with normal and high serum Mg 2+ levels in terms of surrogate markers for vascular calcification ( fig. 3 a-c) . The observed coherence between high serum Mg 2+ levels and diminished vascular calcification in CKD patients suggests that Mg 2+ may represent a potential new therapeutic strategy, at least in these patients. The current findings confirm former in vitro studies using VSMC [10] and studies on different groups of mice [20, 34] consisting of a control group with a mean serum Mg 2+ level of 0.77 8 0.05 mmol/l and a high Mg 2+ group with a mean serum magnesium level of 0.92 8 0.02 mmol/l [35] .
Increased carotid IMT is a strong indicator of arteriosclerosis [36] . Kaplan-Meier survival analysis revealed that patients with high IMT values had a statistically significant higher mortality caused by cardiovascular disease than patients with low IMT values [37] . Therefore, IMT measurements were included into the measures to diagnose and estimate the degree of arteriosclerosis [38] . Due to this knowledge and based on our in vitro findings that Mg 2+ significantly attenuates phosphate-induced vascular calcification in aortic rings cultured in conditions comparable to serum conditions of CKD patients ex vivo/in vivo, the aim was to explore whether there is a significant relationship between Mg 2+ serum levels and carotid IMT values in CKD patients compared to controls without CKD. IMT was significantly higher in CKD patients with normal Mg 2+ serum concentration than in those with a high Mg 2+ serum concentration. IMT of CKD patients with high Mg 2+ serum concentration was comparable to the range of controls without CKD.
Several studies demonstrated that CKD patients develop accelerated arteriosclerosis and particularly distinctive vascular calcification [39] due to atherosclerotic plaques and arterial media calcification [40] . Arteriosclerosis is known to have two major components: (a) arterial wall thickening and (b) arterial wall stiffening [41] . Interestingly, the PWV in CKD patients with normal Mg 2+ serum concentration was significantly higher than in CKD patients with high Mg 2+ serum concentration. The latter group even showed PWV in the range of controls without CKD. The impact of Mg 2+ serum concentration seen on IMT and PWV was independent of albumin, calcium, phosphate, and PTH analyses in both groups.
Since aortic PWV and carotid IMT are known to be predictive for cardiovascular events and mortality [42] , at least in CKD patients paying attention to the fact that highly elevated serum Mg 2+ levels may also induce cardiovascular disturbances.
However, the results of the clinical study are limited by the fact that there are no histopathological data showing that the thickening of artery walls measured only by ultrasonography and/or arterial stiffening measured by waveform analysis are directly a burden of vascular calcification. Nevertheless, IMT and PWV are still useful surrogate markers strongly correlated with the presence of coronary artery disease [41] .
In conclusion, the present study demonstrates that Mg 2+ is a potent inhibitor of vascular calcification ex vivo/in vitro. The elevated serum Mg 2+ concentration of CKD patients may be a compensation mechanism of the organism and supports the presumption that Mg 2+ also acts as an inhibitor of vascular calcification in vivo. This might also explain why CKD patients with high Mg 2+ serum levels had significantly lower values of carotid IMT and aortic PWV values indicating a lower arteriosclerotic burden associated with a lower risk of cardiovascular events and mortality. In this context, further prospective and interventional studies are essential to document a therapeutic effect of Mg 2+ in CKD patients.
